Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury

Cardiovascular Research

Volumn 97, Issue 3, 2013, Pages 432-442

  Wang, Xiaohui ^a   Ha, Tuanzhu ^a   Liu, Li ^b   Zou, Jianghuan ^c   Zhang, Xia ^a   Kalbfleisch, John ^a   Gao, Xiang ^c   Williams, David ^a   Li, Chuanfu ^a  

^a East Tennessee State University   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c NANJING UNIVERSITY   (China)

Author keywords

MicroRNA 146a myocardial I R; NF B activation; Toll like receptors

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LENTIVIRUS VECTOR; MICRORNA 146A; TOLL LIKE RECEPTOR 4; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LENTIVIRINAE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; LENTIVIRUS; MICE; MICE, KNOCKOUT; MICRORNAS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; TRANSFECTION;

EID: 84874242882     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs356     Document Type: Article

References (33)

1. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007;26:133-137.
2. Sheedy FJ, O'Neill LAJ. Adding fuel to fire: microRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008;67:iii50-iii55.
3. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18: 131-140.
4. van Rooij E, Marshall WS, Olson EN. Toward MicroRNA-based therapeutics for heart disease: the sense in antisense. Circ Res 2008;103:919-128.
5. Schroen B, Heymans S. MicroRNAs and beyond: the heart reveals its treasures. Hypertension 2009;54:1189-1194.
6. Fishtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677-684.
7. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009;324:1710-1713.
8. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusioninduced cardial injury. Circulation 2010;122:1308-1318.
9. Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 2009;47:5-14.
10. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009;284:29514-2925.
11. Ren XP,Wu J,Wang X, Sartor MA, Qian J, Jones K et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein Circulation 2009;119:2357-2366.
12. Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. PNAS 2006;103:12481-12486.
13. Linde A, Mosier D, Blecha F, Melgarejo T. Innate immunity and inflammation: new frontiers in comparative cardiovascular pathology. Cardiovasc Res 2007;73:26-36.
14. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
15. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL et al. Modulating Toll-like receptor mediated signaling by (1-.3)-b-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2003;61:538-547.
16. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X et al. Protection against myocardial ischemia/reperfusion injury in TLR4 deficient mice is mediated through a phosphoinositide 3-kinase dependent mechanism. J Immunol 2007;178:7317-7324.
17. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004; 109:784-9.
18. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Shioi T et al. TLR2 ligands induce cardioprotection against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2010;87:694-703.
19. Hua F, Ma J, Ha T, Xia Y, Kelley J, Williams DL et al. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol 2007;190:101-111.
20. Ren D, Wang X, Ha T, Liu L, Kalbfleisch J, Gao X et al. SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages. Biochim Biophys Acta 2012;1832:336-346.
21. Zhou L, Ma W, Yang Z, Zhang F, Lu L, Ding Z et al. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways. Gene Therapy 2004;12:196-202.
22. Ha T, Lu C, Liu L, Hua F, Hu Y, Kelley J et al. TLR2 ligands attenuate cardiac dysfunction in polymicrobial sepsis via a phosphoinositide-3-kinase dependent mechanism. Am J Physiol Heart Circ Physiol 2010;298:H984-H991.
23. Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T et al. Lipopolysaccharide-induced myocardial protection against ischemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovascr Res 2008;78:546-553.
24. Gao M, Ha T, Zhang X, Liu L, Wang X, Kelley J et al. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med 2012; 40:2390-2399.
25. Lu C, Hua F, Liu L, Ha T, Kalbfleisch J, Schweitzer J et al. Scavenger receptor class-A has a central role in cerebral ischemia/reperfusion injury. J Cereb Blood Flow Metab 2010;30:1972-1981.
26. Narula J, Hajjar RJ, Dec GW. Apoptosis in the failing heart. Cardiol Clin 1998;16: 691-710. ix.
27. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997;3:894-899.
28. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107:13-19.
29. Zhao JL, Rao D, Boldin MP, Taganov KD, O'Connell RM, Baltimore D. NF-kB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. PNAS 2011;108:9184-9189.
30. Ma X, Buscaglia LEB, Barker JR, Li Y. MicroRNAs in NF-kB signaling. J Molecu C Bio 2011;3:159-166.
31. Thomas JA, Haudek SB, Koroglu T, Tsen MF, Bryant DD, White DJ et al. IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protect against contractile dysfunction. Am J Physiol Heart Circ Physiol 2003;285:H597-H606.
32. Chen ZJ. Ubiquitination in signaling to and activation if IKK. Immunol Rev 2012;246: 95-106.
33. Suzuki Y, Kim HW, Ashraf M, Haider HKh. Diazoxide potentiates mesenchymal stem cell survival via NF-kappaB-dependent miR-146a expression by targeting Fas. Am J Physiol Heart Circ Physiol 2010;299:H1077-H1082.